Cadila Healthcare Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cadila Healthcare Ltd with three other
companies in this sector in India:
sales of 163.62 billion Indian Rupees [US$2.28 billion]
of which 99%
Dr.Reddy's Laboratories Ltd
(153.85 billion Indian Rupees [US$2.14 billion]
of which 80%
was Global Generics), and
Piramal Enterprises Limited
(132.15 billion Indian Rupees [US$1.84 billion]
of which 53%
was Financial Services).
Cadila Healthcare Ltd reported sales of 131.66 billion Indian Rupees (US$1.84 billion)
March of 2019.
increase of 10.6%
versus 2018, when the company's sales were 119.05 billion Indian Rupees.